Lv32
364 积分 2025-11-04 加入
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
1天前
已完结
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
1个月前
已完结
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
1个月前
已完结
Reprogramming human T cell function and specificity with non-viral genome targeting
1个月前
已完结
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
1个月前
已完结
Expanding access to CAR T cell therapies through local manufacturing
2个月前
已完结
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence
2个月前
已完结
Rapid manufacturing of non-activated potent CAR T cells
2个月前
已完结
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
3个月前
已完结
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
3个月前
已完结
皖公网安备34019202002308
